9 hasil untuk "Cheng PENG"
Menampilkan 1–9 · 0,43 detik · RSS
-
Artikel Jurnal
A serological survey of SARS-CoV-2 in cat in Wuhan
COVID-19 is a new respiratory illness caused by SARS-CoV-2, and has constituted a global public health emergency. Cat is susceptible to SARS-CoV-2. However, the prevalence of SARS-CoV-2 in cats remains largely unknown. Here, we investigated the infection of SARS-CoV-2 in cats during COVID-19…
-
Artikel Jurnal Teks lengkap
Modeling transmission of SARS-CoV-2 Omicron in China
Having adopted a dynamic zero-COVID strategy to respond to SARS-CoV-2 variants with higher transmissibility since August 2021, China is now considering whether, and for how long, this policy can remain in place. The debate has thus shifted towards the identification of mitigation strategies for…
-
Artikel Jurnal Teks lengkap
Hydrogen liquefaction: a review of the fundamental physics, engineering practice and future opportunities
Hydrogen is emerging as one of the most promising energy carriers for a decarbonised global energy system.
-
Artikel Jurnal Teks lengkap
Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques
The 2019 novel coronavirus (SARS-CoV-2) outbreak is a major challenge for public health. SARS-CoV-2 infection in human has a broad clinical spectrum ranging from mild to severe cases, with a mortality rate of ~6.4% worldwide (based on World Health Organization daily situation report). However, the…
-
Artikel Jurnal Teks lengkap
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
Importance: A vaccine against coronavirus disease 2019 (COVID-19) is urgently needed. Objective: To evaluate the safety and immunogenicity of an investigational inactivated whole-virus COVID-19 vaccine in China. Interventions: In the phase 1 trial, 96 participants were assigned to 1 of the 3 dose…
-
Artikel Jurnal Teks lengkap
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
Background The dynamic changes of lymphocyte subsets and cytokines profiles of patients with novel coronavirus disease (COVID-19) and their correlation with the disease severity remain unclear. Methods Peripheral blood samples were longitudinally collected from 40 confirmed COVID-19 patients and…
-
Artikel Jurnal
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test were enrolled prospectively. One dose of 200 mL of convalescent plasma (CP) derived from recently recovered donors with…